$17.16-0.77 (-4.29%)
Alignment Healthcare, Inc.
Alignment Healthcare, Inc. in the Healthcare sector is trading at $17.16. The stock is currently 28% below its 52-week high of $23.87, remaining 6.4% below its 200-day moving average. Technical signals show oversold RSI of 25 and bearish MACD signal, explaining why ALHC maintains its current current market pressure. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. wa...
ALHC, AGX, CIEN, and SIMO make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.
The average of price targets set by Wall Street analysts indicates a potential upside of 32.6% in Alignment Healthcare (ALHC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Shareholders might have noticed that Alignment Healthcare, Inc. ( NASDAQ:ALHC ) filed its first-quarter result this...
Health insurance company Alignment Healthcare (NASDAQ:ALHC) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 33.3% year on year to $1.24 billion. On the other hand, next quarter’s revenue guidance of $1.31 billion was less impressive, coming in 0.9% below analysts’ estimates. Its non-GAAP profit of $0.12 per share was 38.7% above analysts’ consensus estimates.
In the first quarter of 2026, Alignment Healthcare, Inc. reported revenue of US$1,235.2 million, up from US$926.93 million a year earlier, and moved from a net loss to net income of US$11.42 million, with earnings per share turning positive. The company paired this shift to profitability with 33.3% year-over-year revenue growth and a 30.9% increase in Medicare Advantage membership, while slightly raising full-year guidance across membership, revenue, adjusted gross profit and adjusted...